Technical View | 19,450 level remains crucial for further uptrend in Nifty50
The Options data indicated that 19,500-19,600 is likely to be the key hurdle zone for the Nifty50, with 19,300 support, but in between, 19,400 seems to be crucial for either side of the trade.
The Options data indicated that 19,500-19,600 is likely to be the key hurdle zone for the Nifty50, with 19,300 support, but in between, 19,400 seems to be crucial for either side of the trade. The Options data indicated that 19,500-19,600 is likely to be the key hurdle zone for the Nifty50, with 19,300 support, but in between, 19,400 seems to be crucial for either side of the trade. Moneycontrol Latest News Read More
The Options data indicated that 19,500-19,600 is likely to be the key hurdle zone for the Nifty50, with 19,300 support, but in between, 19,400 seems to be crucial for either side of the trade.
Taking Stock: Market snaps 3-day gains to end marginally lower; realty worst hit
Hero MotoCorp, Coal India, Bajaj Finance, JSW Steel and Divis Labs were among major losers on the Nifty, while gainers included Sun Pharma, BPCL, NTPC, Axis Bank and Dr Reddy#39;s Labs.
Hero MotoCorp, Coal India, Bajaj Finance, JSW Steel and Divis Labs were among major losers on the Nifty, while gainers included Sun Pharma, BPCL, NTPC, Axis Bank and Dr Reddy#39;s Labs. Hero MotoCorp, Coal India, Bajaj Finance, JSW Steel and Divis Labs were among major losers on the Nifty, while gainers included Sun Pharma, BPCL, NTPC, Axis Bank and Dr Reddy#39;s Labs. Moneycontrol Latest News Read More
Hero MotoCorp, Coal India, Bajaj Finance, JSW Steel and Divis Labs were among major losers on the Nifty, while gainers included Sun Pharma, BPCL, NTPC, Axis Bank and Dr Reddy#39;s Labs.
Sixteenth Finance Commission and ‘beyond the GDP’ paradigm
The analytical framework of the 16th Finance Commission will be #39;beyond GDP#39;, by integrating human development variables. Will it also apply a #39;gender lens#39; in the inter-governmental fiscal transfer framework within the terms of reference?
The analytical framework of the 16th Finance Commission will be #39;beyond GDP#39;, by integrating human development variables. Will it also apply a #39;gender lens#39; in the inter-governmental fiscal transfer framework within the terms of reference? The analytical framework of the 16th Finance Commission will be #39;beyond GDP#39;, by integrating human development variables. Will it also apply a #39;gender lens#39; in the inter-governmental fiscal transfer framework within the terms of reference? Moneycontrol Latest News Read More
The analytical framework of the 16th Finance Commission will be #39;beyond GDP#39;, by integrating human development variables. Will it also apply a #39;gender lens#39; in the inter-governmental fiscal transfer framework within the terms of reference?
ASK Automotive IPO: Financials, shareholding, comparison with peers in 5 charts
The price band of the issue, which will close on November 9, has been fixed at Rs 268-282 per share
The price band of the issue, which will close on November 9, has been fixed at Rs 268-282 per share The price band of the issue, which will close on November 9, has been fixed at Rs 268-282 per share Moneycontrol Latest News Read More
The price band of the issue, which will close on November 9, has been fixed at Rs 268-282 per share
IRCTC Q2: Net profit rises 30.36% to Rs 294.67 crore, revenue up 23.51%
The Board has declared an interim dividend of Rs 2.50 per equity share of face value of Rs 2 each for the financial year 2023-24.
The Board has declared an interim dividend of Rs 2.50 per equity share of face value of Rs 2 each for the financial year 2023-24. The Board has declared an interim dividend of Rs 2.50 per equity share of face value of Rs 2 each for the financial year 2023-24. Moneycontrol Latest News Read More
The Board has declared an interim dividend of Rs 2.50 per equity share of face value of Rs 2 each for the financial year 2023-24.
JB Pharma Q2 results: Net Profit up 35% to Rs 150.5 crore
The pharma company had reported a net profit of Rs 111.1 crore in the year-ago period.
The pharma company had reported a net profit of Rs 111.1 crore in the year-ago period. The pharma company had reported a net profit of Rs 111.1 crore in the year-ago period. Moneycontrol Latest News Read More
The pharma company had reported a net profit of Rs 111.1 crore in the year-ago period.
Protean eGov Technologies IPO bought 2.35 times on second day
Protean eGov Technologies IPO | The company is selling 61.91 lakh shares through the public issue, at the upper price band, comprising only an offer-for-sale by investors.
Protean eGov Technologies IPO | The company is selling 61.91 lakh shares through the public issue, at the upper price band, comprising only an offer-for-sale by investors. Protean eGov Technologies IPO | The company is selling 61.91 lakh shares through the public issue, at the upper price band, comprising only an offer-for-sale by investors. Moneycontrol Latest News Read More
Protean eGov Technologies IPO | The company is selling 61.91 lakh shares through the public issue, at the upper price band, comprising only an offer-for-sale by investors.
हिन्दी 
English